DE3677710D1 - Cefuroximaxetil-dragee. - Google Patents

Cefuroximaxetil-dragee.

Info

Publication number
DE3677710D1
DE3677710D1 DE8686307459T DE3677710T DE3677710D1 DE 3677710 D1 DE3677710 D1 DE 3677710D1 DE 8686307459 T DE8686307459 T DE 8686307459T DE 3677710 T DE3677710 T DE 3677710T DE 3677710 D1 DE3677710 D1 DE 3677710D1
Authority
DE
Germany
Prior art keywords
cefuroximaxetil
dragee
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686307459T
Other languages
English (en)
Inventor
Jamshed Anwar
David Samuel Deutsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10585921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3677710(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE3677710D1 publication Critical patent/DE3677710D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DE8686307459T 1985-09-30 1986-09-29 Cefuroximaxetil-dragee. Expired - Lifetime DE3677710D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524001A GB8524001D0 (en) 1985-09-30 1985-09-30 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DE3677710D1 true DE3677710D1 (de) 1991-04-04

Family

ID=10585921

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8686307459T Expired - Lifetime DE3677710D1 (de) 1985-09-30 1986-09-29 Cefuroximaxetil-dragee.
DE19863633292 Withdrawn DE3633292A1 (de) 1985-09-30 1986-09-30 Pharmazeutische zusammensetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19863633292 Withdrawn DE3633292A1 (de) 1985-09-30 1986-09-30 Pharmazeutische zusammensetzung

Country Status (29)

Country Link
US (1) US4897270A (de)
EP (1) EP0223365B1 (de)
JP (1) JP2661662B2 (de)
KR (1) KR940000233B1 (de)
AT (1) AT393081B (de)
AU (1) AU594082B2 (de)
BE (1) BE905518A (de)
CA (1) CA1282331C (de)
CH (1) CH672736A5 (de)
CY (1) CY1563A (de)
DE (2) DE3677710D1 (de)
DK (1) DK175349B1 (de)
ES (1) ES2002382A6 (de)
FR (1) FR2591597B1 (de)
GB (2) GB8524001D0 (de)
GR (1) GR862464B (de)
HK (1) HK84990A (de)
IE (1) IE59089B1 (de)
IL (1) IL80165A (de)
IT (1) IT1196644B (de)
LU (1) LU86613A1 (de)
NL (1) NL8602466A (de)
NO (1) NO173636C (de)
NZ (1) NZ217720A (de)
PH (1) PH25702A (de)
PT (1) PT83459B (de)
SA (1) SA91120189B1 (de)
SE (1) SE8604114L (de)
ZA (1) ZA867318B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
AT393955B (de) * 1990-03-30 1992-01-10 Martin Dr Leixnering Einrichtung zur nachbehandlung frischer beugesehnenverletzungen
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
GB2256587A (en) * 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (de) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
DE69905452D1 (de) * 1998-03-03 2003-03-27 Daewoong Pharmaceutical Co Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
ES2204605T3 (es) * 1999-06-11 2004-05-01 Ranbaxy Laboratories Limited Compuestos de sabor enmascarado.
IN191239B (de) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
EP1414417A1 (de) * 2000-12-01 2004-05-06 Abdul Rehman Wockhardt Research Centre Khan Pharmazeutische formulierung
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
HRP20020923A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
WO2004058227A1 (en) * 2002-12-31 2004-07-15 Boehringer Ingelheim International Gmbh Film coated tablet comprising an extract of red vine leaves
US20050079213A1 (en) * 2003-06-06 2005-04-14 Unilab Pharmatech Ltd Pharmaceutical compositions
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
CN1909889B (zh) * 2004-01-09 2010-06-02 韩美药品株式会社 头孢呋辛酯颗粒及其制备方法
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
UA90668C2 (ru) * 2004-02-19 2010-05-25 Бёрингер Ингельхайм Интернациональ Гмбх Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство
DE602005003343T2 (de) * 2004-04-12 2008-09-11 Pfizer Products Inc., Groton Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
WO2008065504A1 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
ES2809713T3 (es) 2012-02-22 2021-03-05 Duchesnay Inc Formulación de doxilamina y piridoxina y/o metabolitos o sales de estas
EP2833873A1 (de) * 2012-04-04 2015-02-11 Mahmut Bilgic Filmtablettenformulierungen mit cefuroxim-axetil und clavulansäure
WO2014174847A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
WO2014174846A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
TWI654977B (zh) 2013-07-22 2019-04-01 達契斯奈股份有限公司 用於控管噁心及嘔吐之組合物
EP3210607A4 (de) 2014-10-23 2018-06-06 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3372015A (en) * 1963-11-15 1968-03-05 Pittsburgh Plate Glass Co Method of and apparatus for equalizing the cooling of a glass sheet supported on a bending mold
US3383236A (en) * 1964-04-17 1968-05-14 Merck & Co Inc Continuous pharmaceutical film coating process
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3981984A (en) * 1968-04-01 1976-09-21 Colorcon Incorporated Color film coating of tablets and the like
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4470980A (en) * 1980-03-07 1984-09-11 Interx Research Corp. Method of increasing oral absorption of β-lactam antibiotics
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8324152D0 (en) * 1983-09-09 1983-10-12 Glaxo Group Ltd Chemical process
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
EP0147780A3 (de) * 1984-01-03 1987-03-11 Merck & Co. Inc. Vorrichtung zur Freisetzung von Arzneistoffen
JPS60169416A (ja) * 1984-02-14 1985-09-02 Taisho Pharmaceut Co Ltd 素錠の表面処理方法
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.

Also Published As

Publication number Publication date
GB8524001D0 (en) 1985-11-06
NO863863L (no) 1987-03-31
IT8648492A0 (it) 1986-09-29
AU6323286A (en) 1987-04-02
IL80165A0 (en) 1986-12-31
DE3633292A1 (de) 1987-04-09
LU86613A1 (fr) 1988-04-05
HK84990A (en) 1990-10-25
SA91120189B1 (ar) 2001-10-07
GB2181052B (en) 1989-10-18
IT1196644B (it) 1988-11-16
EP0223365A3 (en) 1988-06-08
NO173636C (no) 1994-01-12
DK462486D0 (da) 1986-09-29
US4897270A (en) 1990-01-30
GB2181052A (en) 1987-04-15
IE862564L (en) 1987-03-30
NZ217720A (en) 1988-07-28
GR862464B (en) 1987-02-02
FR2591597B1 (fr) 1989-06-02
BE905518A (fr) 1987-03-30
KR870002832A (ko) 1987-04-13
NO863863D0 (no) 1986-09-29
ES2002382A6 (es) 1988-08-01
ATA260986A (de) 1991-01-15
IE59089B1 (en) 1994-01-12
NL8602466A (nl) 1987-04-16
PT83459A (en) 1986-10-01
AU594082B2 (en) 1990-03-01
ZA867318B (en) 1987-05-27
IL80165A (en) 1991-06-10
JPS62123118A (ja) 1987-06-04
FR2591597A1 (fr) 1987-06-19
KR940000233B1 (ko) 1994-01-12
AT393081B (de) 1991-08-12
EP0223365A2 (de) 1987-05-27
DK175349B1 (da) 2004-09-06
DK462486A (da) 1987-03-31
PT83459B (pt) 1989-05-12
CY1563A (en) 1991-05-17
PH25702A (en) 1991-09-18
EP0223365B1 (de) 1991-02-27
SE8604114D0 (sv) 1986-09-29
SE8604114L (sv) 1987-03-31
GB8623340D0 (en) 1986-11-05
NO173636B (no) 1993-10-04
CA1282331C (en) 1991-04-02
CH672736A5 (de) 1989-12-29
JP2661662B2 (ja) 1997-10-08

Similar Documents

Publication Publication Date Title
DE3681208D1 (de) Fluormeter.
DE3685608D1 (de) 8-phenylxanthine.
DE3685611D1 (de) Polysiloxanelastomer.
DE3677710D1 (de) Cefuroximaxetil-dragee.
ATE55980T1 (de) 2-hydroxy-3-phenoxypropylamine.
DE3668776D1 (de) Endotubus.
DE3668381D1 (de) Contactlinse.
FI861104A0 (fi) Golvmatta.
FI860381A (fi) Piperidinfoereningar.
FI865074A (fi) Folieelement foer elektrisk uppvaermning.
DE3668885D1 (de) Fluorbenzylester.
FI853006L (fi) Monterbar roeklaoda.
FI853077A0 (fi) Flerskiktig pressfilt.
DE3669772D1 (de) Russblaeser.
DE3678182D1 (de) Perfluorpolycycloalkane.
DE3677472D1 (de) Blockierverhinderer.
FI852498A0 (fi) Styv tablett.
DE3680606D1 (de) Loetapparat.
DE3680574D1 (de) L-aminoacylasen.
DE3683724D1 (de) Zahnstutz.
FI875435A0 (fi) Transport- och lagringsbehaollare foer kylvaror.
DE3673520D1 (de) Perfluorpolyaether.
DE3670979D1 (de) Raederfalzapparat.
FI864350A (fi) Haollare foer plantak.
FI861836A (fi) Uppteckningsmaterial.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN